We can find oneness in meditation, in community, or in awe at the beauty around us. Another option: psychedelic medicines that can catalyze a connection with the self, with nature, or the cosmos. Good Chemistry points us on the right path to forging true and deeper attachments with our own souls, to one another, and even to our planet, helping us heal ourselves and our world.

Can psychedelic drugs help us tackle the biggest problems we face globally? Can they heal the cultural, spiritual, and political wounds we’re wrestling with? Psychedelics have hit the mainstream as powerful new mental health treatments. But as clinicians explore what these molecules can do for our individual minds, The Bigger Picture goes further to illuminate how psychedelics can help us find new ways to make sense of and come through the crises we face around the world.

Few drugs in history have generated as much controversy as MDMA—or held as much promise. Once vilified as a Schedule I substance that would supposedly eat holes in users’ brains, MDMA (also known as Molly or Ecstasy) is now being hailed as a therapeutic agent that could transform the field of mental health and outpace psilocybin and ketamine as the first psychedelic approved for widespread clinical use. In I Feel Love, science journalist Rachel Nuwer separates fact from fantasy, hope from hype, in the drug’s contested history and still-evolving future.

In this comprehensive guide, Strasburg, accompanied by a foreword from the inventor of Internal Family Systems, Dr. Richard Schwartz, Ph.D., sheds light on the transformative power of psychedelic-assisted psychotherapy in our modern world. Whether you're curious about working with psilocybin, MDMA, ketamine, or other psychedelic medicines, this book provides the knowledge and tools necessary to excel in this unique therapeutic modality.

Exploring the latest developments in the flourishing field of modern psychedelic psychotherapy, this book shares practical experiences and insights from both elders and newer research voices in the psychedelic research and clinical communities.